Jupiter Endovascular, Inc. is a privately held medical technology company headquartered in Menlo Park, California, developing Endoportal Control, a platform technology that fixes a flexibly navigated endoportal device into a stable state inside the vasculature so a catheter-based intervention can be delivered with the precision and control of direct surgical access. Its lead product is the Vertex Pulmonary Embolectomy System for acute pulmonary embolism, evaluated in the SPIRARE I first-in-human study (NCT06571760) and the FDA-approved SPIRARE II U.S. pivotal study. The company exited stealth with $21M and later closed an oversubscribed Series B surpassing its $40M target, led by Sonder Capital. Jupiter Endovascular is a pre-commercial clinical-stage device manufacturer and publishes no developer program, no API, and no machine-readable interface of any kind.
Jupiter Endovascular is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Medical Technology, Healthcare, and Interventional Cardiology.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: jupiter-endovascular
name: Jupiter Endovascular
description: Jupiter Endovascular, Inc. is a privately held medical technology company headquartered in Menlo Park, California,
developing Endoportal Control, a platform technology that fixes a flexibly navigated endoportal device into a stable state
inside the vasculature so a catheter-based intervention can be delivered with the precision and control of direct surgical
access. Its lead product is the Vertex Pulmonary Embolectomy System for acute pulmonary embolism, evaluated in the SPIRARE
I first-in-human study (NCT06571760) and the FDA-approved SPIRARE II U.S. pivotal study. The company exited stealth with
$21M and later closed an oversubscribed Series B surpassing its $40M target, led by Sonder Capital. Jupiter Endovascular
is a pre-commercial clinical-stage device manufacturer and publishes no developer program, no API, and no machine-readable
interface of any kind.
url: https://raw.githubusercontent.com/api-evangelist/jupiter-endovascular/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
deliveryModel:
model: unknown
open_source: false
commercial: false
callable_host: false
label: Delivery model not determined — needs a product licence on record
confidence: low
source:
- none
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source:
- security
generated: '2026-09-02'
method: derived
specificationVersion: '0.20'
created: '2026-08-23'
modified: '2026-08-23'
tags:
- Company
- Medical Devices
- Medical Technology
- Healthcare
- Interventional Cardiology
- Pulmonary Embolism
- Clinical Trials
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: DomainSecurity
url: security/jupiter-endovascular-domain-security.yml
- type: Website
url: https://jupiterendo.com/
- type: PrivacyPolicy
url: https://jupiterendo.com/privacy-policy/
x-enrichment:
date: '2026-08-23'
status: minimal
artifacts_added: 2
pass: local-v1
x-coverage:
state: none
reason: not-a-software-company
detail: Jupiter Endovascular is a pre-commercial clinical-stage manufacturer of a physical Class III catheter device (the
Vertex Pulmonary Embolectomy System, in the SPIRARE I and II trials) — software is not the product, and the only web property
is a SiteGround-hosted WordPress marketing site at jupiterendo.com that answers every path, including a deliberately bogus
control path, with an identical 202 sg-captcha interstitial; there is no GitHub organization, no package on npm or PyPI,
and the api/developer/docs subdomains all wildcard to a NameBright parking host rather than to any developer surface.
evidence:
- url: https://jupiterendo.com/openapi.json
status: 202
- url: https://jupiterendo.com/.well-known/agent-card.json
status: 202
- url: https://api.github.com/orgs/jupiter-endovascular
status: 404
- url: https://registry.npmjs.org/jupiter-endovascular
status: 404
checked: '2026-08-23'
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.
Kin Score
How this is scored →